{
    "clinical_study": {
        "@rank": "21511", 
        "arm_group": {
            "arm_group_label": "natural In Vitro Fertilization cycle", 
            "description": "Patient doing following natural In Vitro fertilization cycle"
        }, 
        "brief_summary": {
            "textblock": "Perifollicular Doppler could reflect the quality of the follicle's vascularization and,\n      consequently, the one of the oocyte that ensues from it. Perifollicuar Doppler is the\n      analysis, in ultrasound, of the blood flow in vessels surrounding the follicle.\n\n      The goal of this study is to evaluate if there is a link, in natural cycle In Vitro\n      Fertilization, between the quality of the vascularization and the one of the oocyte, the\n      embryo and the pregnancy."
        }, 
        "brief_title": "Perifollicular Doppler in Natural Cycle In Vitro Fertilization", 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient with a natural In Vitro Fertilization cycle.\n\n          -  Patient under 38 years old\n\n          -  Body mass indice under 35\n\n          -  Ovulatory cycles between 20-35 days\n\n        Exclusion Criteria:\n\n          -  Patient with a stimulation In Vitro Fertilization cycle\n\n          -  Patient with a naturalIn Vitro Fertilization cycle with egg donor\n\n          -  Patient with a natural In Vitro Fertilization cycle with freezing embryo\n\n          -  Smoking patient\n\n          -  Diabetic patient\n\n          -  Patient with treatment of antihypertensive drug, anticoagulant, antiplatelet,\n             vasodilator\n\n          -  Body mass indice over 35\n\n          -  Patient over 38 years old\n\n          -  Patient without ovulation or cycle over 35 days\n\n          -  Percutaneous Epididymal Sperm Aspiration (PESA), Testicular Sperm Extraction (TESE)\n             or micro TESE"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "38 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Women following In Vitro Fertilization cycle"
            }
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01668212", 
            "org_study_id": "OVO-11-01"
        }, 
        "intervention": {
            "arm_group_label": "natural In Vitro Fertilization cycle", 
            "description": "Doppler Ultrasound", 
            "intervention_name": "Doppler ultrasound", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Montr\u00e9al", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "H4P 2S4"
                }, 
                "name": "Ovo Fertilit\u00e9"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "1", 
        "official_title": "Perifollicular Doppler in Natural Cycle In Vitro Fertilization", 
        "overall_official": {
            "affiliation": "Clinique ovo", 
            "last_name": "Delphine Delrieu, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The measurements are done twice; on days of induction and oocyte retrieval. During the blood sample collection on the day of the induction, there is also a measurement of progesterone, estradiol and luteinizing hormone (LH).", 
            "measure": "Quality perifollicular doppler and quality of the oocyte", 
            "safety_issue": "No", 
            "time_frame": "2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01668212"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "OVO R & D", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "OVO R & D", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}